Detalhe da pesquisa
1.
Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America.
J Infect Dis
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809190
2.
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.
J Infect Dis
; 226(5): 852-861, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610135
3.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Lancet
; 397(10268): 27-38, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308427
4.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Lancet
; 397(10268): 39-50, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308429
5.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
MMWR Morb Mortal Wkly Rep
; 71(24): 786-790, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709073
6.
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.
J Infect Dis
; 224(12 Suppl 2): S398-S404, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590135
7.
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Lancet
; 394(10193): 148-158, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174831
8.
Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era.
Emerg Infect Dis
; 25(7): 1363-1369, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31082331
9.
Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
Clin Infect Dis
; 67(suppl_1): S35-S41, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376081
10.
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Clin Infect Dis
; 67(suppl_1): S115-S120, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376084
11.
Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
Clin Infect Dis
; 67(suppl_1): S4-S17, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376097
12.
Triumphs of Immunization.
J Infect Dis
; 224(12 Suppl 2): S307-S308, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590131
13.
Sabin Strain Inactivated Polio Vaccine for the Polio Endgame.
J Infect Dis
; 221(4): 504-505, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788498
14.
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
J Infect Dis
; 210 Suppl 1: S447-53, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316866
15.
Expert review on poliovirus immunity and transmission.
Risk Anal
; 33(4): 544-605, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22804479
16.
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.
Risk Anal
; 33(4): 606-46, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23550968
17.
Completing Polio Eradication: The Case for Antiviral Drugs.
J Infect Dis
; 215(3): 333-334, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932609
18.
Achieving and maintaining polio eradication--new strategies.
N Engl J Med
; 371(16): 1476-9, 2014 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25317869
19.
Mucosal immunity to poliovirus.
Mucosal Immunol
; 15(1): 1-9, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239028
20.
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.
Lancet Infect Dis
; 21(4): 559-568, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284114